Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS approval · 2016-02-23

Clinical Trial Update: Athrectomy and Drug Eluting Balloon Therapy (ADEBT) on the Femoral Popliteal Arteries

View source ↗

Summary

The Athrectomy with Drug Eluting Balloon Therapy (ADEBT) has been approved for marketing to treat Peripheral Arterial Disease in the femoral-popliteal arteries.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Athrectomy with Drug Eluting Balloon Therapy (ADEBT)

Snippet

Sponsor: Changi General Hospital | Conditions: Peripheral Arterial Disease | Status: APPROVED_FOR_MARKETING